Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C‐Reactive Protein Level Is Below the Limit of Detection or If High‐Sensitivity C‐Reactive Protein Is Used: An Analysis in the DESIR Cohort-Reference-Cited by-同舟云学术

Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C‐Reactive Protein Level Is Below the Limit of Detection or If High‐Sensitivity C‐Reactive Protein Is Used: An Analysis in the DESIR Cohort

Published:2015-01-28 Issue:2 Volume:67 Page:408-413
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Machado Pedro¹²,Navarro‐Compán Victoria¹³,Landewé Robert⁴,Gaalen Floris A.¹,Roux Christian⁵,Heijde Désirée¹

Affiliation:

1. Leiden University Medical CenterLeidenThe Netherlands

2. University of CoimbraCoimbraPortugal

3. University Hospital La PazMadridSpain

4. Amsterdam Rheumatology Center, Amsterdam, The Netherlands, and Atrium Medical CenterHeerlenThe Netherlands

5. Paris Descartes UniversityParisFrance

Funder

Fundação para a Ciência e a Tecnologia

Wyeth

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.38921

Reference17 articles.

1. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

2. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

3. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

4. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

5. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF inhibitors

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T2* cartilage mapping in early axial spondyloarthritis: diagnostic accuracy and correlation with clinical characteristics, sacroiliitis MRI scorings, and diffusion metrics;European Radiology;2024-07-24

2. The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis;Aktuelle Rheumatologie;2024-04-17

3. Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?;The Journal of Rheumatology;2024-04-15

4. Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA;Modern Rheumatology Journal;2024-02-17

5. Assessment of Circulating lncRNA H19 in Ankylosing Spondylitis Patients and Its Correlation with Disease Activity;Journal of Personalized Medicine;2023-05-30